Riehl melanosishttps://en.wikipedia.org/wiki/Riehl_melanosis
Riehl melanosis imhando yekubata dermatitis, inotanga ne pruritus, erythema, uye pigmentation iyo inopararira zvishoma nezvishoma iyo, kana yasvika pamwero wakati, inomira. Kubuda kwezuva mushure mekushandiswa kwezvimwe zvinonhuwira kana makirimu zvinogona kukonzera chirwere.

☆ Mune 2022 Stiftung Warentest mhedzisiro kubva kuGermany, kugutsikana kwevatengi neModelDerm kwakangodzikira zvishoma pane nekubhadharwa kwe telemedicine kubvunzana.
      References Riehl Melanosis 32491369 
      NIH
      Riehl melanosis inowanzozivikanwa se pigmented contact dermatitis. Imhando yeganda rinokonzerwa neallergies, kazhinji inokonzereswa nekunhuhwirira uye zvimwe zvinhu zvinowanikwa muzvigadzirwa zvekuzora. Pasinei nekurondedzerwa semhando yedermatitis, Riehl melanosis inoratidza kuchinja kwemavara muganda, nezviratidzo zviduku zvekutsamwa. Zvinowanzoitika kune vanhu vane ganda rakasvibira. Tsvagiridzo ichangoburwa yakaongorora kushanda kwe mid-fluence QSNY 1064-nm laser kurapwa kwekugadzirisa yakadzika pigmentation ine chekuita ne Riehl melanosis. Chimwe chidzidzo chakabatanidza marapirwo akasiyana, anosanganisira low-fluence 1064-nm Q-switched Nd: YAG laser, hydroquinone cream, uye oral tranexamic acid, zvichikonzera kuvandudzika kukuru kuvarwere vazhinji.
      Riehl melanosis (RM), commonly called pigmented contact dermatitis, is considered an acquired form of allergic contact dermatitis, typically to fragrance and other ingredients of cosmetic products. Although it is considered as a dermatitis, it presents clinically with hyperpigmentation over the face and shows pigment incontinence with minimal eczematous changes on histology. The condition is more commonly seen in dark-skinned people, causing an important psychosocial impact. A recent study showing the higher effectiveness of mid-fluence QSNY 1064-nm laser in targetting the deep pigmentation of RM has also been conducted. Another study used a combination of therapies to include low-fluence, 1064-nm, Q-switched Nd: YAG laser, hydroquinone cream, and oral tranexamic acid, with the majority of patients experiencing significant improvement.
       Research Advances in the Treatment of Riehl’s Melanosis 37168093 
      NIH
      Riehl's melanosis imhando yeganda reganda rinokonzerwa nekusangana nemamwe maallergen uye kuratidzwa nezuva. Inotungamira kukukurumidza, kufambira mberi kwegrey-brown pigmentation yeganda, iyo inogona kukanganisa zvakanyanya varwere vese mupfungwa uye mumuviri. Nepo chikonzero chaicho che Riehl's melanosis chisati chazivikanwa, tsvakiridzo iripo inoratidza hukama hwakasimba nekuratidzwa kweallergen. Pakurapa, zvese zvechivanhu mishonga nelaser therapy zvakaedzwa, kazhinji pamwe nekushandiswa kwe bleaching agents akaiswa paganda. Laser therapy, kunyanya kushandisa Q-switched Nd:YAG laser, yakaratidza mhedzisiro inovimbisa pakurapa Riehl's melanosis. Kubatanidza nzira dzakasiyana dzekurapa dzakatungamira kune mhedzisiro yakanaka.
      Riehl's melanosis (RM) is a contact photodermatitis, with fast progressive gray-brown skin pigmentation as the main manifestation, which can seriously affect the psychology and physiology of patients. Currently, although the etiological factors of Riehl's melanosis is still be unknown, the existing literature proves clearly the cause of it is related to the contacting with suspected allergens. For decades, there has been no standard method for the treatment of RM, but with both conventional drug therapy and laser therapy having been attempted. Topical application of bleaching agents is mainly used as an auxiliary treatment modality. The laser treatment modality remains a hot spot, among which Q-switched Nd:YAG laser is well received for RM. Positive outcomes have been achieved by the combined treatment modalities attempted in recent years also achieve positive outcomes.